Search Results

Filter
  • 1-10 of  18 results for ""United States""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Report

Trial to Evaluate the Safety, Immunogenicity, and Efficacy of Malaria Infection in Malaria Naïve Adults

  • Source: Beadle C, Hoffman SL. Htory of malar the Uned States Naval Forces at war: World War through the Vtnam conflt. Cl fect D. 1993 Feb;16(2):320-9.Breman JG, Al MS,

Record details

×
Report

HIV Vaccine Trial in Thai Adults

  • Source: Nayaphan S, Putthum P, Karnasuta C, Eamsa C, de Souza M, Morgan P, Polon V, Benenson M, VanCott T, Ratto-K S, K J, Thapta D, Garner R, Bussarat V, Sgharaj P, el-Hab R, Gurunathan S, Heyward W, Bx D,

Record details

×
Report

Double-blind, Randomized, Controlled Study of Safety, Immunogenicity and Efficacy of a Candidate Malaria Vaccine

  • Source: Phyangkul S, Gettayacam M, Mler RS, Lyon JA, Angov E, Tongtawe P, Ruble DL, Heppner DG Jr, Kester KE, Ballou WR, Dgs CL, Voss G, Cohen JD, Walsh DS. Pre-clal evaluatn of the malar vacce candate P.

Record details

×
Report

Comparison of Full-dose Flu Vaccine to Half-dose Flu Vaccine

  • Source: Engler RJ, Nelson MR, Klote MM, VanRaden MJ, Huang CY, Cox NJ, Klimov A, Keitel WA, Nichol KL, Carr WW, Treanor JJ; Walter Reed Health Care System Influenza Vaccine Consortium. Half- vs full-dose

Record details

×
Report

Safety and Immunogenicity Study of a Dengue Virus DNA Vaccine

  • Source: An Open-Label, Dose Escalation, Phase I Safety, and Immunogenicity Trial of a Dengue Serotype 1 (DEN-1) Premembrane (prM) and Envelope (E) DNA Vaccine (D1ME100) in Healthy Adults Volunteers

Record details

×
Report

Safety Study of Candidate Malaria Vaccine FMP1/AS02A in Healthy Adults in Bandiagara, Mali

  • Source: Stoute JA, Gombe J, Whers MR, Sngla J, McKney D, Onyango M, Cummgs JF, Mman J, Tucker K, Soson L, Stewart VA, Lyon JA, Angov E, Leach A, Cohen J, Kester KE, Ockenhouse CF, Holland CA, Dgs CL, Wtes J,

Record details

×
Report

Phase 1 Trial of a Malaria Vaccine in Young Kenyan Children

  • Source: Phyangkul S, Gettayacam M, Mler RS, Lyon JA, Angov E, Tongtawe P, Ruble DL, Heppner DG Jr, Kester KE, Ballou WR, Dgs CL, Voss G, Cohen JD, Walsh DS. Pre-clal evaluatn of the malar vacce candate P.

Record details

×
Report

A Study to Determine Whether 2 Investigational Malaria Vaccines Are Safe, Protective Against Malaria in Adults

  • Source: Dutta S, Lalha PV, Ware LA, Barbosa A, Moch JK, Vassell MA, Feta BB, Kov S, Kolodny N, Heppner DG, Haynes JD, Lanar DE. Puratn, characteratn, and munogeny of the refolded ectodoma of the Plasmodm

Record details

×
Report

NMRC-M3V-Ad-PfCA Vaccine - Clinical Trial 1

  • Source: Ophorst OJ, Radosev K, Havenga MJ, Pau MG, Holterman L, Berkhout B, Goudsm J, TsujM. munogeny and protectn of a recombant human adenovus serotype 35-based malar vacce agast Plasmodm yoel me. fect

Record details

×
Report

A Study to Determine the Effects of an Investigational Malaria Vaccine Given to Adults Living in the United States and Thereafter to Adults Living in Kenya

  • Source: Phase 1a Open-label Dose Escalation Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of the Candidate Plasmodium Falciparum Malaria Protein 010 (FMP010) Administered Intramuscularly

Record details

×
  • 1-10 of  18 results for ""United States""